I am a radiologist who specializes in body imaging, with a particular expertise in hepatopancretobiliary tumors. My clinical work focuses on CT and MRI of the chest, abdomen, and pelvis. As the Department of Radiology co-chair of the Hepatopancreatobiliary Disease Management Team, I guide the interpretation of tumors of the liver, pancreas, and bile ducts in collaboration with our gastroenterologists, medical oncologists, and surgical oncologists.
My research interests are centered on advanced imaging techniques and radiomics for hepatopancreatobiliary tumors. Novel magnetic resonance (MR)-based imaging techniques, including diffusion-weighted imaging and perfusion imaging, can be used to evaluate treatment response with the potential of improving the selection of appropriate therapies for patients. These imaging techniques can provide insight into early tumor response during therapy, thus providing valuable feedback to oncologists. I am also collaborating with computer scientists to investigate the potential of radiomics, which involves harnessing the big data intrinsic to medical imaging to predict tumor pathology, genetics, and response to treatment.
As the MRI safety officer, I lead a team of physicians, nurses, supervisors, and radiology technologists to ensure that safe practices for MR are adopted. Our goal is the complete safety of patients and staff members who are in the MR environment.
- Clinical Expertise: Abdominal Radiology
- Languages Spoken: English
- Education: MD, Weill Cornell Medical College; PhD, Weill Cornell Graduate School of Medical Sciences
- Residencies: NYU Langone Medical Center
- Fellowships: NYU Langone Medical Center
- Board Certifications: Diagnostic Radiology
Sadot E, Simpson AL, Do RK, Gonen M, Shia J, Allen PJ, D’Angelica MI, DeMatteo RP, Kingham TP, Jarnagin WR. Cholangiocarcinoma: Correlation between Molecular Profiling and Imaging Phenotypes. PLoS One. 2015 Jul 24;10(7):e0132953
Simpson AL, Adams LB, Allen PJ, D’Angelica MI, DeMatteo RP, Fong Y, Kingham TP, Leung U, Miga MI, Parada EP, Jarnagin WR, Do RK. Texture analysis of preoperative CT images for prediction of postoperative hepatic insufficiency: a preliminary study. J Am Coll Surg. 2015 Mar;220(3):339-46
Konstantinidis IT, Do RK, Gultekin DH, Gönen M, Schwartz LH, Fong Y, Allen PJ, D’Angelica MI, DeMatteo RP, Klimstra DS, Kemeny NE, Jarnagin WR. Regional chemotherapy for unresectable intrahepatic cholangiocarcinoma: a potential role for dynamic magnetic resonance imaging as an imaging biomarker and a survival update from two prospective clinical trials. Ann Surg Oncol. 2014 Aug;21(8):2675-83
Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.
Clinical Trials Co-Investigated by Richard Kinh Gian Do
- A Phase I Study of Stereotactic Body Radiotherapy after Chemotherapy for Locally Advanced Inoperable Pancreatic Cancer
- A Phase II Study of Hepatic Arterial Infusion with Floxuridine and Dexamethasone plus Systemic Gemcitabine and Oxaliplatin in Patients with Inoperable Intrahepatic Cholangiocarcinoma
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more